|Earlybird Venture Capital||Managing Partner||Germany|
From treatment to early detection: How are MedTech and diagnostic companies adapting their business models and unlocking the value of data?
Thom Rasche joined Earlybird as a Venture Partner in 2003 and was promoted to Partner in 2006. Since 2014 he has been Partner at Earlybird Health Management GmbH & Co. KG.
Thom has more than 16 years experience as investor. Further, he is a seasoned executive in the medical device and diagnostic sectors with over 29 years of operational experience. Since he joined Earlybird,
Thom has been responsible for the medical device portfolio and new investments in this area. He is currently on the board of EBS Technologies GmbH (Berlin), Miracor Medical SA (Awans), Atlantic Therapeutics Ltd. (Galway), Alesi Surgical Ltd. (Cardiff) and Polares Medical SA (Ecublens).
Before joining Earlybird, Thom was with Johnson & Johnson Medical Devices and Diagnostics group in various international senior management roles, lastly as Managing Director for Ethicon-EndoSurgery Germany.
Thom Rasche holds a Degree as Diplom Kaufmann (MBA equivalent) from the University of Applied Sciences in Lüneburg, Germany.